1. Home
  2. ERC vs EOLS Comparison

ERC vs EOLS Comparison

Compare ERC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Multi-Sector Income Fund

ERC

Allspring Multi-Sector Income Fund

HOLD

Current Price

$9.11

Market Cap

260.9M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.71

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERC
EOLS
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.9M
284.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ERC
EOLS
Price
$9.11
$5.71
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
70.4K
651.1K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
8.37%
N/A
EPS Growth
N/A
1.23
EPS
0.72
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
$12.77
N/A
Revenue Growth
N/A
11.61
52 Week Low
$8.72
$3.86
52 Week High
$9.78
$12.16

Technical Indicators

Market Signals
Indicator
ERC
EOLS
Relative Strength Index (RSI) 46.66 66.93
Support Level $8.90 $4.02
Resistance Level $9.44 $5.52
Average True Range (ATR) 0.09 0.27
MACD -0.01 0.07
Stochastic Oscillator 23.78 83.15

Price Performance

Historical Comparison
ERC
EOLS

About ERC Allspring Multi-Sector Income Fund

Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: